Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-05-24
1991-04-09
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514337, 514422, 514469, 546269, 548525, 549320, 549471, 549 60, A61K 3138, A61K 3144, C07D40900, C07D30512
Patent
active
050065491
ABSTRACT:
Novel 7-Aroyl-4-Hydroxy-3-Methyl-Benzofurans of the following general formula (I) are disclosed: ##STR1##
REFERENCES:
patent: 4172082 (1979-10-01), Moore
patent: 4431656 (1984-02-01), Katsumi et al.
patent: 4548948 (1985-10-01), Ward et al.
patent: 4743606 (1988-05-01), Lazer
patent: 4775679 (1988-10-01), Chang et al.
patent: 4816473 (1989-03-01), Dunn
Annual Reports in Medicinal Chemistry, vol. 22, Chapter 20, p. 205, (1987).
Annual Reports in Medicinal Chemistry, vol. 23, Section 4, pp. 184-189 (1989).
Katsumi, Ikuo et al., Studies on Styrene Derivatives II Synthesis and Anti-inflammatory Activity of 3,5-Di-tert-butyl-4-hydroxystyrenes, Chem. Pharm. Bull., vol. 34, pp. 1619-1627 (1986).
Lazer, E.S. et al., Antiinflammatory 2,6-Di-tert-butyl-4-(2-arylethenyl) phenyls, J. Med. Chem., vol. 32, pp. 100-104 (1989).
Hammond Milton L.
Zambias Robert A.
Merck & Co. , Inc.
Panzer Curtis C.
Pfeiffer Hesna J.
Siegel Alan
LandOfFree
Novel 7-aroyl-4-hydroxy-3-methyl-benzofurans as dual inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 7-aroyl-4-hydroxy-3-methyl-benzofurans as dual inhibitors , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 7-aroyl-4-hydroxy-3-methyl-benzofurans as dual inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034768